Skip to content

Catalyst Pharmaceutical CPRX Change in Other Assets

Change in Other Assets at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.18M-107%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-$3.05M-306%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$32K-94.5%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$28K
Scholar Rock logo
Scholar RockSRRK
$37K+142%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$13.4M+2,512%

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0.0×
Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's change in other assets?
Catalyst Pharmaceutical (CPRX) reported change in other assets of -$2.45M in Q1 2026.
How has Catalyst Pharmaceutical's change in other assets changed year-over-year?
Catalyst Pharmaceutical's change in other assets increased by 65.1% year-over-year, from -$7.02M to -$2.45M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.